Leukemia, Lymphocytic, Chronic, B-Cell
Showing NaN - NaN of 5
Lymphoma, Non-Hodgkin, Leukemia, Lymphocytic, Chronic, B-Cell Trial in Worldwide (JNJ-75348780)
Recruiting
- Lymphoma, Non-Hodgkin
- Leukemia, Lymphocytic, Chronic, B-Cell
-
Birmingham, Alabama
- +43 more
Jan 27, 2023
Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma Trial in Worldwide (BMS-986403, Fludarabine, Cyclophosphamide)
Recruiting
- Leukemia, Lymphocytic, Chronic, B-Cell
- Lymphoma
- BMS-986403
- +2 more
-
Birmingham, Alabama
- +24 more
Jul 6, 2022
Leukemia, Lymphocytic, Chronic, B-Cell Trial in Worldwide (CC-122, Ibrutinib, Obinutuzumab)
Completed
- Leukemia, Lymphocytic, Chronic, B-Cell
- CC-122
- +2 more
-
La Jolla, California
- +23 more
Aug 20, 2021
Leukemia, Lymphocytic, Chronic, B-Cell Trial in Spain (Cyclophosphamide, Fludarabine, Rituximab)
Completed
- Leukemia, Lymphocytic, Chronic, B-Cell
- Cyclophosphamide
- +2 more
-
Vitoria, Alava, Spain
- +32 more
Jul 27, 2018
Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, Large B-Cell, Diffuse, Lymphoma, Follicular Trial in Worldwide (Part 1 (Dose
Terminated
- Leukemia, Lymphocytic, Chronic, B-Cell
- +4 more
- Part 1 (Dose Escalation): Duvortuxizumab
- Part 2 (Dose Expansion): Duvortuxizumab
-
Detroit, Michigan
- +19 more
Dec 19, 2018